|
OMIM |
Link |
Information gain |
01 |
|
CDAN2
|
[NCBI]
|
0.0015337
|
|
|
orotic aciduria ii
|
[NCBI]
|
0.000326197
|
|
|
VRNI
|
[NCBI]
|
0.000323902
|
|
|
hypomagnesemia, hypertension, and hypercholesterolemia, mitochondrial
|
[NCBI]
|
0.000184253
|
|
|
orotic aciduria i
|
[NCBI]
|
0.000115414
|
|
|
breast cancer
|
[NCBI]
|
7.57852e-05
|
|
|
sickle cell anemia
|
[NCBI]
|
7.57852e-05
|
|
|
SMA1
|
[NCBI]
|
7.19927e-05
|
|
|
porphyria, acute intermittent
|
[NCBI]
|
6.91364e-05
|
|
|
SLC29A2
|
[NCBI]
|
6.65409e-05
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
6.25718e-05
|
|
|
ZFP36
|
[NCBI]
|
6.06451e-05
|
|
|
FRDA
|
[NCBI]
|
5.99079e-05
|
|
|
severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency
|
[NCBI]
|
5.96587e-05
|
|
|
APOB
|
[NCBI]
|
5.03366e-05
|
|
|
TYMS
|
[NCBI]
|
4.7367e-05
|
|
|
TLR7
|
[NCBI]
|
4.73204e-05
|
|
|
ADA
|
[NCBI]
|
4.38915e-05
|
|
|
UCK1
|
[NCBI]
|
4.34593e-05
|
|
|
EGF
|
[NCBI]
|
3.79977e-05
|
|
|
TRN
|
[NCBI]
|
3.60374e-05
|
|
|
CVID
|
[NCBI]
|
3.59293e-05
|
|
|
RA
|
[NCBI]
|
3.35445e-05
|
|
|
TRG1
|
[NCBI]
|
3.3237e-05
|
|
|
UCK2
|
[NCBI]
|
3.3237e-05
|
|
|
SLC28A2
|
[NCBI]
|
3.1419e-05
|
|
|
SLC28A1
|
[NCBI]
|
3.1419e-05
|
|
|
SLC28A3
|
[NCBI]
|
3.1419e-05
|
|
|
TLR8
|
[NCBI]
|
3.1419e-05
|
|
|
TRNP3
|
[NCBI]
|
3.1419e-05
|
|
|
U2AF2
|
[NCBI]
|
3.00676e-05
|
|
|
RPS25
|
[NCBI]
|
2.89909e-05
|
|
|
P2RY6
|
[NCBI]
|
2.89909e-05
|
|
|
RP
|
[NCBI]
|
2.77974e-05
|
|
|
SIP1
|
[NCBI]
|
2.66603e-05
|
|
|
MTTI
|
[NCBI]
|
2.60657e-05
|
|
|
SLC29A1
|
[NCBI]
|
2.60657e-05
|
|
|
CCL4
|
[NCBI]
|
2.55309e-05
|
|
|
PCBP2
|
[NCBI]
|
2.5045e-05
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
2.47092e-05
|
|
|
APOBEC1
|
[NCBI]
|
2.45998e-05
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
2.39668e-05
|
|
|
TAF1
|
[NCBI]
|
2.08016e-05
|
|
|
POLR2A
|
[NCBI]
|
2.02107e-05
|
|
|
SMN1
|
[NCBI]
|
1.42382e-05
|
|
|
CF
|
[NCBI]
|
1.37391e-05
|
|
|
CEACAM5
|
[NCBI]
|
9.73294e-06
|
|
|
FMR1
|
[NCBI]
|
9.6746e-06
|
|
|
DCK
|
[NCBI]
|
9.42552e-06
|
|
|
HDC
|
[NCBI]
|
7.36779e-06
|
|
|
GPI
|
[NCBI]
|
7.19013e-06
|
|
|
EPO
|
[NCBI]
|
6.39385e-06
|
|
|
VEGF
|
[NCBI]
|
5.48966e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
5.10544e-06
|
|
|
NGFB
|
[NCBI]
|
4.83393e-06
|
|
|
SOD2
|
[NCBI]
|
4.60758e-06
|
|
|
GAPDH
|
[NCBI]
|
3.09139e-06
|
|
|
HBB
|
[NCBI]
|
2.60856e-06
|
|
|
SLE
|
[NCBI]
|
2.31975e-06
|
|
|
TNF
|
[NCBI]
|
3.41465e-07
|
|
|
MBP
|
[NCBI]
|
1.75715e-07
|
|
|
PCNA
|
[NCBI]
|
4.17856e-08
|
|
|
BDNF
|
[NCBI]
|
1.11829e-08
|
|
|
GFAP
|
[NCBI]
|
1.07621e-08
|
|
|
PRL
|
[NCBI]
|
3.03552e-09
|
|